2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Katherine Poruk, MD, a board-certified and fellowship-trained surgical oncologist and researcher, is the latest addition to the Cancer Treatment Centers of America®, Atlanta, physician team.
Katherine Poruk, MD, a board-certified and fellowship-trained surgical oncologist and researcher, is the latest addition to the Cancer Treatment Centers of America® (CTCA), Atlanta, physician team. Shewill focus on gastrointestinal and hepatopancreatic cancers, as well as sarcomas and melanomas.
Dr. Poruk earned her medical degree from the University of Utah School of Medicine in Salt Lake City and completed a general surgery residency at Johns Hopkins Hospital in Baltimore. She completed her fellowship in complex surgical oncology at Memorial Sloan-Kettering Institute in New York City.
“We’re thrilled that Dr. Poruk has chosen to join our team,” said Dr. Jeffrey Metts, chief of staff at CTCA® Atlanta. “Not only does her clinical background feature nationally renowned healthcare institutions, but her passion is also personal.”
The loss of her father to pancreatic cancer crystallized Dr. Poruk’s calling to oncology and has also shaped the way she practices medicine.
“My goal is to serve patients in a comprehensive and connected way,” said Dr. Poruk. “CTCA gives me that opportunity within a specialty hospital that is collaborative, innovative and compassionate.”
Dr. Poruk is a member of several organizations, including the Society of Surgical Oncology, American Association of Cancer Research, American College of Surgeons, Americas Hepato-Pancreato-Biliary Association and Association of Academic Surgery. She has also authored several publications, abstracts and book chapters.
About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA® publishes treatment results annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.